“Approved research project” means a scientific research project, which is approved by the commission and which focuses on the genetic, biochemical, viral, microbiological and environmental causes of cancer, and may include, but is not limited to, behavioral, socio-economic, demographic and psychosocial research or research into methods of clinical treatment; or which focuses on pain management and palliative care for persons diagnosed with cancer.

“Commission” means the New Jersey State Commission on Cancer Research established pursuant to this act.

“Institutional support services” means all services, facilities, equipment, personnel and expenditures associated with the creation and maintenance of approved research projects.

“Pediatric cancer research project” means a scientific research project approved pursuant to this act, which scientific research project focuses on the causes, prevention, education, screening, treatment, or cure of pediatric cancer, or the symptoms or effects experienced by patients following completion of a course of treatment for pediatric cancer, and may include, but shall not be limited to, basic, clinical, and epidemiologic research.

“Qualifying research institution” means the Coriell Institute for Medical Research in Camden, New Jersey, Rutgers–The State University, Rowan University, Princeton University and any other institution approved by the commission, which is conducting an approved research project. For the purposes of sections 2 through 5 of P.L.2021, c.210 (C. 52:9U-6.4 et al.), “qualifying research institution” may include academic medical institutions, State or local government agencies, public or private organizations within New Jersey, and any other institution approved by the commission, which is conducting a pediatric cancer research project.

L.1983, c.6, s.3; amended 1984, c.237, s.1; 2000, c.63, s.1; 2012, c.45, s.131; 2021, c.210, s.4.